Status:
COMPLETED
Evaluation of the Sensitivity and Specificity of a Novel Quality of Life Tool to Assess the Treatment Satisfaction in Psoriasis Patients
Lead Sponsor:
Clinact
Collaborating Sponsors:
LEO Pharma
Conditions:
Psoriasis
Eligibility:
All Genders
18+ years
Brief Summary
The severity of psoriasis can be influenced by a great variety of factors including extent of the disease, lesions location and impact on quality of life. The current standard of care for psoriasis is...
Eligibility Criteria
Inclusion
- Age \> 18 years
- Patient for whom the dermatologist decided to initiate a treatment by Kyntheum® according to SmPC.
- Patient who signed an informed consent
Exclusion
- Vulnerable subjects according to the law;
- pregnant, parturient or breast feeding women;
- deprived of their freedom by administrative, medical or legal decision or who is under trusteeship/guardianship;
- legally protected, or unable to express their consent to participate;
- With no affiliation to a social security system;
- Psychologically/linguistically unable to express their consent to participate
- With an hypersensitivity to at least one of the excipients of Kyntheum®
- Participating at the same time in another clinical trial
Key Trial Info
Start Date :
December 4 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 13 2023
Estimated Enrollment :
143 Patients enrolled
Trial Details
Trial ID
NCT04765332
Start Date
December 4 2020
End Date
March 13 2023
Last Update
March 19 2024
Active Locations (27)
Enter a location and click search to find clinical trials sorted by distance.
1
Cliniques Universitaires Saint Luc - UCLouvain
Brussels, Belgium
2
Private practice
Geel, Belgium
3
Private practice
Genk, Belgium
4
Private practice
Kalken, Belgium